Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map[®] technology in the Balkan region
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Genetic Analysis AS enters an agreement with ELTA90 Group to distribute and launch GA-map[®] technology in the Balkan region

OSLO, NORWAY – 8 June 2023: Molecular diagnostics specialist, Genetic Analysis AS (“GA”) has entered a distribution agreement with ELTA90 Group (“ELTA90”), a Sofia based fast growing distributor of Laboratory diagnostics into the Balkan region with operations in several countries. One of ELTA90 focus areas is specialized molecular diagnostics for the clinical diagnostics and research market.  

Ronny Hermansen, CEO, Genetic Analysis, comments:
“GA is proud to have ELTA90 Group as a partner in the Balkan region and is thrilled to see that our GA-map® platform gets acknowledgement from customers in new markets globally. The GA-map® platform offers a high throughput lab testing platform with an integrated cloud-based software algorithm for immediate result presentation of the microbiome analysis.  As the regulatory requirements in Europe gets stricter, we are happy to see that more and more labs are appreciating our CE-IVD GA-map® solution.”

The market demand for gut microbiome assessments is rapidly increasing globally in the private healthcare services, medical clinics, and academic research with focus on identifying and categorizing the patient’s microbiota. Together with ELTA90, GA can now offer its standardized gut microbiome testing platform to the Balkan countries to meet the growing interest and raise awareness of the impact of microbiota alteration and dysbiosis.

Dr. Theodor Zamfirov, CEO, ELTA90, comments:
“E90 are excited to offer the GA-map® Microbiome testing platform to our Lab customers all over the Balkan region, as we see that the demand for accurate, fast turnaround microbiome testing is increasing rapidly. GA-map® will be a great complementary to our growing business of specialty molecular diagnostics, as several labs in the Balkan countries are focusing on supplying the European market with high quality diagnostics. The core value of ELTA90 is to offer the highest quality products to our customers, and we are proud to add GA-map® to our portfolio of high-end products.”

Bifogade filer

2023-06-08 GA Press Release - ELTA90 - Englishhttps://mb.cision.com/Public/20846/3782729/a6f29ecd895195d9.pdf

Nyheter om Genetic Analysis

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Genetic Analysis

Senaste nytt